{"product_id":"westpharma-business-model-canvas","title":"West Pharmaceutical Services Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWest Pharma Business Model Canvas: Strategic Blueprint, Revenue \u0026amp; Partner Insights\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind West Pharmaceutical Services’s business model—this concise Business Model Canvas exposes how the company creates value for drug developers, secures durable partnerships, and monetizes precision components in a regulated, high-growth market.\u003c\/p\u003e\n\u003cp\u003eDive into the complete canvas to see customer segments, key activities, cost structure, and revenue streams mapped with company-specific insights—ideal for investors, consultants, and innovators.\u003c\/p\u003e\n\u003cp\u003ePurchase the full, editable Word and Excel files to benchmark, adapt, and accelerate your strategic planning with a professional, ready-to-use framework.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiopharmaceutical Strategic Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWest Pharmaceutical Services partners with top-tier pharma firms to co-develop containment systems for novel biologics, embedding packaging design in early clinical stages to cut compatibility failures by up to 40% and speed time-to-market; by 2025 these alliances support handling of complex large-molecule therapies that now represent over 60% of new biologic launches, contributing to West’s reported 2024 revenue mix where specialty pharma solutions grew faster than legacy products.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Manufacturing Organizations (CMOs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWest partners widely with CMOs and CDMOs that run fill-finish for pharma makers, embedding FluroTec stoppers and other proprietary components into high-volume lines; in 2024 West reported 2024 product sales of $1.5 billion and said partnerships supported a \u0026gt;30% share of injectable packaging volume in top 20 global CDMOs, keeping the supply chain integrated from component production to final drug packaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRaw Material and Polymer Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWest secures multi-year supply agreements with specialty elastomer and polymer vendors to meet medical-grade purity; in 2024 they reported \u0026gt;90% supplier continuity for critical materials, cutting production risk. These partners co-develop low-extractable, high-barrier formulations—West cites a 15% reduction in extractables in new components—and help navigate regulatory audits and global disruptions. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Academic Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCollaborations with universities and medical centers fund studies on drug-device compatibility and polymer degradation, supporting West’s R\u0026amp;D that reported $182.6M in 2024 R\u0026amp;D spend (FY 2024). These ties accelerate next-gen polymer and delivery work and funnel specialized engineering talent into West’s labs via internships and joint appointments.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDrives fundamental science on compatibility and degradation\u003c\/li\u003e\n\u003cli\u003eEnables next-gen polymers and delivery mechanisms\u003c\/li\u003e\n\u003cli\u003ePipeline for specialized talent—interns, postdocs, joint hires\u003c\/li\u003e\n\u003cli\u003eSupports R\u0026amp;D scale—$182.6M FY 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Healthcare Standard Bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eWest Pharmaceutical Services engages with regulators such as the FDA and EMA and sits on industry working groups to shape primary-packaging and delivery-system standards, helping ensure products meet evolving safety and quality rules and cutting customers' time-to-market.\u003c\/p\u003e\n\u003cp\u003eIn 2024 West reported $2.8B revenue; regulatory alignment lowered qualification cycles by an estimated 15–25% for key biologics clients, speeding launches and reducing rework costs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eActive with FDA, EMA, ISO working groups\u003c\/li\u003e\n\u003cli\u003eParticipation cuts qualification time ~15–25%\u003c\/li\u003e\n\u003cli\u003e2024 revenue $2.8B supports compliance investments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartner ecosystem cuts failures 40%, fuels \u0026gt;30% CDMO injectable share, $2.8B revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWest’ key partnerships—pharma co-devs, CDMOs, material suppliers, academia, regulators—cut compatibility failures ~40%, supported \u0026gt;30% injectable packaging share in top 20 CDMOs, and underpinned 2024 revenue $2.8B with $182.6M R\u0026amp;D.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma co-dev\u003c\/td\u003e\n\u003ctd\u003eCompatibility ↓\u003c\/td\u003e\n\u003ctd\u003e40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCDMOs\u003c\/td\u003e\n\u003ctd\u003eMarket share\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSuppliers\u003c\/td\u003e\n\u003ctd\u003eSupplier continuity\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\/academia\u003c\/td\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$182.6M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulators\u003c\/td\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$2.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Business Model Canvas for West Pharmaceutical Services outlining customer segments, channels, value propositions, key partners, activities, resources, cost structure, and revenue streams tied to their injectable drug delivery systems and services, with competitive advantages, SWOT-linked insights, and investor-ready narrative for strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of West Pharmaceutical Services’ business model with editable cells to quickly identify how its contract manufacturing, device innovation, and material science capabilities relieve customer pain points in drug packaging and delivery.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Material Science R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eContinuous R\u0026amp;D in elastomeric formulations and film coatings is West Pharmaceutical Services core differentiator, reducing drug-container interaction and supporting regulatory stability; R\u0026amp;D spend reached $145M in 2024 and management increased materials programs by 28% into late 2025 to target mRNA and cell and gene therapy storage needs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Precision Precision Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWest operates ISO-class cleanrooms producing billions of components yearly with reported defect rates near 0.001% and 2024 manufacturing revenue of $1.8B; proprietary services like Westar wash and terminal sterilization drive higher margins by turning commodity parts into validated, ready-to-use drug container systems. This scale and sub-micron precision create a durable moat, supporting ~40% gross margins on finished systems and long-term supply contracts with top 10 pharma customers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSystem Integration and Device Design\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWest Pharmaceutical designs and assembles complex delivery systems—wearable injectors and auto-injector platforms—moving beyond stoppers to full-system solutions; in 2024 device sales grew 12% YoY, contributing about 35% of West’s $2.4B revenue, reflecting heavy investment in mechanical engineering and human factors testing to meet safety and usability standards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality Assurance and Regulatory Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eA large share of West Pharmaceutical Services’ operations focus on maintaining ISO-certified quality management systems and producing technical dossiers and validation packages used in customer regulatory filings; in 2024 West invested about $95M in quality, regulatory, and R\u0026amp;D support to sustain these programs.\u003c\/p\u003e\n\u003cp\u003eThis activity supplies the data customers need to demonstrate packaging safety to regulators, underpinning trust with agencies and global pharma clients and supporting West’s 2024 revenue of $2.6B.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eProvides technical dossiers for filings\u003c\/li\u003e\n\u003cli\u003eDelivers validation\/data packages proving safety\u003c\/li\u003e\n\u003cli\u003eSupports global regulator and client trust\u003c\/li\u003e\n\u003cli\u003e~$95M invested in quality\/regulatory (2024)\u003c\/li\u003e\n\u003cli\u003eSupports $2.6B 2024 revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eWest runs a global logistics network delivering critical containment and delivery components to over 5,000 customer sites worldwide, prioritizing demand forecasting, inventory optimization, and regionalized production to cut lead times and tariff exposure.\u003c\/p\u003e\n\u003cp\u003eBy 2025 West digitized supply chains—real-time tracking, automated replenishment, and analytics—reducing stockouts by ~30% and lowering working capital tied to inventory by an estimated $50–75M.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e5,000+ customer sites served\u003c\/li\u003e\n\u003cli\u003e30% fewer stockouts (post-digitization)\u003c\/li\u003e\n\u003cli\u003e$50–75M working capital reduction (estimate)\u003c\/li\u003e\n\u003cli\u003eRegional plants to cut lead times and tariffs\u003c\/li\u003e\n\u003cli\u003eReal-time tracking and automated replenishment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-margin devices \u0026amp; ISO-ready R\u0026amp;D: $2.6B revenue, $240M ops spend, $50–75M WC freed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCore R\u0026amp;D (elastomers\/films) + ISO cleanroom manufacturing, device design, regulatory dossier prep, and global logistics—2024 R\u0026amp;D $145M, quality\/regulatory $95M, revenue $2.6B, manufacturing rev $1.8B, device rev 35% of $2.4B; digitization cut stockouts ~30% and freed $50–75M working capital.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$145M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuality\/regulatory\u003c\/td\u003e\n\u003ctd\u003e$95M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal revenue\u003c\/td\u003e\n\u003ctd\u003e$2.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing rev\u003c\/td\u003e\n\u003ctd\u003e$1.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice share\u003c\/td\u003e\n\u003ctd\u003e35% of $2.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStockout reduction\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorking capital saved\u003c\/td\u003e\n\u003ctd\u003e$50–75M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Business Model Canvas preview you see is the exact document you’ll receive after purchase—not a mockup or sample—and it reflects the full structure, content, and professional formatting of the final deliverable.\u003c\/p\u003e\n\u003cp\u003eUpon completing your order, you’ll instantly download the same Business Model Canvas file, ready to edit, present, and share in the provided formats without substitutions or missing sections.\u003c\/p\u003e\n\u003cp\u003eWe provide full transparency: what’s visible in this preview is a direct snapshot of the final product, so there are no surprises—just the complete, production-ready canvas you’ll own.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749266567545,"sku":"westpharma-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/westpharma-business-model-canvas.png?v=1772213876","url":"https:\/\/matrixbcg.com\/products\/westpharma-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}